Archive for May, 2015


In Silico Genesis signed up NDA contract (Confidentiality Agreement) with University of Bristol, following initial discussions with faculty members of Centre for Computational Chemistry, School of Chemistry, University of Bristol, England in May/June 2013. This NDA contract was communicated via Research Enterprise Development, on behalf of the Department of Chemistry, for the official signatory of the University of Bristol. This confidentiality agreement bears a specific scope of the permitted purpose, which is relating to research on potential drugs for new medicinal targets for influenza treatments.

We met at e-Infrastructure South Conference and his presentation was of great interest to the work of In Silico Genesis, in the area of the current drug resistance of the existing flu medicines and how it can be alleviated. In order to achieve this, it is necessary to understand what it is causing the resistance at the structural level. His work was spot on, beautifully so.

What was more impressive still, was how the University of Bristol handled the NDA contract, in a most professional and thorough manner. At the time, I was sceptical of anything that was from outside of my Oxford University. They showed me the grace and understanding, instead of walking away from what could have been very unpleasant to them. For that, I am thankful to the University of Bristol, regardless of what may become of this NDA contract in the years to come.

Advertisements

In Silico Genesis signed up a Confidential Disclosure Agreement with Imanova, a spin-off company from GlaxoSmithKline (GSK), in April 2015. This CDA was originally signed by the CEO of Imanova on the 19th of April 2013, following a mutual interest identified in the area of CNS, whilst both companies attending One Nucleus CNS Leadership Seminar series in London on the 11th of February 2013.

Since then, Imanova and In Silico Genesis have both been selected to represent the strengths of British companies on the UK Trade and Investment CNS Trade Mission to British Embassy Seoul and British Embassy Tokyo, in the first week of November 2014. I was very impressed by the quality of the work presented by Imanova, and more so by his warmth and genuine respect which he showed to the people of South Korea and of Japan at the Embassies.

I had the pleasure of introducing my father to the CEO of Imanova at British Embassy Seoul. Then, I was deeply touched by how he opened his seminar at British Embassy Tokyo, sharing with the audience openly what Japan really meant to him and his daughter. I returned my signed copy of the original CDA bearing his signature, to the CEO of Imanova on the 19th of April, 2015. He is a hard-working CEO and believes in what Imanova can do to help people.